well welcome to you and all the other new posters to the

New Post Public Reply Private Reply Replies (0) Message Board
4kids goodbuys #45631
429
well welcome to you and all the other new posters to the IPIX board here on ihang ..

bottom line is this .. *imo*

NR never covers one second b4 being forced to .. because almost always
NR can outlast mgmt and unsophisticated retail investors and *do* as you've
noted .. death by 1000 cuts .. which is both exhausting and demoralizing to retail

Innovation has almost no institutional investors .. but imo what Innovation
has which most OTC targets don't have .. is an aware and savvy mgmt team
in regards to the manipulation that was done against the company as noted
by the *aggressive* response out of mgmt years back .. this to me is the most
important aspect .. second only to Innovation's platform .. and why i not only remain invested .. but keep providing (albeit minimal to some i know) bid support on a regular basis .. i add *shares* almost every week now .. and even knowing
what is being done and how it's being done .. my CB (cost basis) is in the RED

you may remember the very lengthy time IPIX spent around 70c .. this matters
because as i've posted in this venue months ago .. the way NR works those cycles
is to try and get to the next level down (35c) .. but it takes its toll on what NR actually has to report on a *regular* basis .. whose visual tells one side of NRs' story .. rather *clearly* ( plus 30% )

this is why one tracks daily volume (which is made of up trades) .. notes who is showing on RT l2 (and who isn't) .. notes who factually reports to Finra for the
MM Monthly (because only those who do actual *activity* report to Finra and reveal in total *decoys r us* which is the majority of MMs' *showing*) .. what the *legal* short reveals .. which as i noted yesterday .. is telling in what hasn't been *covered* since 2.15.18 .. ( 1.1M when i posted IPIX was just shy of 70c).. it all adds to the package of data retail can utilize to their advantage ..

i've long since learned this pattern .. and while some may wish to believe it is unique to IPIX .. it isn't .. what is unique imo (along with a few other *targets*)
is the declining volume and rising %s .. which indicate NR has *significant* problems of their own making

Quote:
so in a nutshell .. from *reporting* on 2.15.18 .. pre 2.22.18's *52 week low reset* for the first time since 5.10.17 to today's *data* .. NR has managed to lower a *reported* legal short of 1147767 to 1113653 .. a difference of 34,114 *shares*


Read More: https://investorshangout.com/post/view?id=503...z5F7yGfA1f

https://investorshangout.com/post/view?id=5036071

so the way this will usually go *if* (and again please realize what NR is up against is not only a savvy mgmt team imo .. but a time line NR doesn't control per se) .. the usual patterns in play get played out .. is all will get to *watch* NRs' resets
done in price point i noted last week .. imo 30c to 39c .. b4 the next round gets underway .. if you were watching last week ... resets went off @ approx 425c
earlier this week on *volume* .. resets went off @ 38c .. last 2 days .. mostly 35c to 36c .. the next effort *if able* is imo 325c .. 30c .. this could be tomorrow .. it could be next week .. or it may never happen because mgmt's execution can always trump NR

again i come to back to why this is being done .. NR desperately needs shares and they don't care how they get them because what NR has done because of years of efforts coming home to roost .. is having almost all the liquidity usually able to be provided .. squeezed out of IPIX since last year

usually retail will sell for 2 reasons .. stock gets taken up high enough or stock gets taken low enough .. this is why it also matters when NR last *ran* IPIX UP
those take ups have happened with less and less frequency for the last year +
but all can *see* that each round of what i refer to as controlled take ups .. come
with less volume and almost always at a lower price point than done previously

one of the reasons i've pointed out 25c .. is there are some firms that will not allow buys when an stock (regardless of where traded) falls below 25c .. (only sells)
which makes the uneven playing field against retail by non retail .. accelerate

hope this helps .. it's actually not difficult to comprehend .. but it is time consuming to learn a different way of *seeing* aspects pertaining to OTC targets

i always come back to those who've been invested for years .. is the company's platform better today than it was in late 2014? .. 2015? .. 2016? and 2017?

if the answer is yes ... then ask yourself was the stock illegally manipulated
then or now?

NRs' playbook is very clear as to MO .. that is exactly what happened *imo* of the *significant* take UP of CTIX (IPIX) @ the EO 2014 .. and why the *efforts* came into play back in 2015 ..

it's also why i posted out the *volume* avgs from 2015 .. a few weeks ago ..
i'll try to edit in for any new eyes ..

glty with your trades/investments

edit ..

Detailed Quote:CTIX
CELLCEUTIX CORPORATION
3.55Down -0.06 (-1.66 %) AS OF 3:56:47PM ET 01/26/2015


Last Trade 3.55
Trade Time 3:56:47pm ET

Change -0.06
% Change -1.66%


Bid 3.54
Bid Size 200

Ask 3.58
Ask Size 200

Open 3.545
Day High 3.64
Day Low 3.28

Previous Close
01/26/2015 3.55

52-Week High
12/12/2014 4.93

52-Week Low
04/15/2014 1.49


Price Performance (Last 52 Weeks)
01/26/2015 +88.83%


Volume 0
Volume (10 day Average) 1,291,129
Volume (90 day Average) 693,156




4kids
Quote:

4kids, new here and have just been reading posts, but I wonder when you say we could have another reset to .25, I’m thinking that the results from Prurisol would short circuit that if we get the results out within the next week or two. I’m more of a short term trader and this death of a thousand cuts is killing all of us. I try not to get married to a stock but IPIX’s story is just too compelling. I’m sure many are under water with IPIX stock and many are probably worse off than myself, but I’ve lost well over 50% on my investment so far. Do you have a time frame on the .25 reset? Also to those who understand the results we got yesterday, I’m a little confused on the, in my thinking, good results for some of the placebo results. I see that Brilacidin delays, shortens and/ or prevents OM and can’t understand why the stock hasn’t at least taken the results and partnership with Evonik as a major, major plus. From previous posts I understand we are under a short attack but why isn’t the general public buying with this kind of great news out there? It seems IPIX IR isn’t reaching the general public so that we could overcome the shorters. I hate reading great releases only to watch as we go down in share price. I’m sure I don’t have to tell anyone how frustrating this is. GLTA

Goodbuys









Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 60

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 50

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

American Atomics Welcomes New Director and Operational Experts

Updated Category News Views 236

American Atomics Welcomes a New Addition to Its Leadership Team American Atomics Inc. (the "Company") is excited to announce the addition of Mr. Henrik Mikkelsen to its Board of Directors. With over 30 years of expertise in investment banking and energy trading, Mr. Mikkelsen will significantly bolster the company's direction. His recent role as Managing Partner and CIO...

Continue Reading
Coinbase Price Target Surges: Insights from Top Analysts

Updated Category News Views 127

Analyst Predictions for Coinbase's Future In the dynamic landscape of finance, the role of expert analysts becomes paramount, especially when it comes to predicting movements in stock prices. A recent surge in forecasts suggests that Coinbase Global, Inc. (NASDAQ: COIN) could experience substantial growth in its stock value. With the price target moving from $280 to an...

Continue Reading
Insights on Ultra Clean Holdings' Upcoming Class Action Lawsuit

Updated Category News Views 192

Understanding the Class Action Lawsuit Against Ultra Clean Holdings The Gross Law Firm is here to inform investors of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) about an important class action lawsuit that is currently pending. This notice is directed towards shareholders who acquired shares of UCTT during the specified class period. The opportunity to participate in this...

Continue Reading
Logistics Automation Market Expected to Hit $85.19 Billion

Updated Category News Views 78

Growth of the Logistics Automation Market The logistics automation market is experiencing a transformative shift, with projections indicating that it will reach an impressive US$ 85.19 billion by 2030. This signifies a substantial increase from the US$ 35.21 billion recorded in 2022, with a compound annual growth rate (CAGR) of 11.7% expected over the period spanning 2022...

Continue Reading
Exploring Wynn Resorts' Recent Options Activity and Insights

Updated Category News Views 115

Understanding the Latest Trends in Wynn Resorts' Options Wynn Resorts has been capturing the attention of investors lately, particularly those who are willing to take a more aggressive approach in the marketplace. The underlying sentiment indicates strong, bullish activity surrounding Wynn Resorts (NASDAQ: WYNN). This is particularly significant for both institutional and...

Continue Reading